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Episodic memory deficits are traditionally seen as the hallmark cognitive 
impairment during the prodromal continuum of late-onset Alzheimer’s disease 
(LOAD). Previous studies identified early brain alterations in regions subserving 
executive functions in asymptomatic, middle-aged offspring of patients with LOAD 
(O-LOAD), suggesting that premature episodic memory deficits could be 
associated to executive dysfunction in this model. We hypothesized that O-LOAD 
would exhibit reduced executive performance evidenced by increased errors and 
decreased strategy use on an episodic memory task. We assessed 32 
asymptomatic middle-aged O-LOAD and 28 age-equivalent control subjects (CS) 
with several tests that measure executive functions and the Rey Auditory Verbal 
Learning Test (RAVLT) to measure memory performance. All tests were scored 
using both traditional and process scores (quantification of errors and strategies 
underlying overall performance). T-tests were used to compare performance between 
both groups and Spearman correlations were implemented to measure associations 
between variables. O-LOAD participants exhibited decreased executive performance 
compared to CS as it relates to initiation time (Tower of London), mental switching 
(Trail Making Test B), and interference effects (Stroop Word-Color condition). 
Traditional RAVLT measures showed a poorer performance by O-LOAD and 
RAVLT process scores revealed increased interference effects on this group. 
Positive correlations (rs) were found between the executive measures and several 
RAVLT measures for O-LOAD but not for CS. In conclusion, O-LOAD participants 
exhibited early subtle cognitive changes in executive processing. Observed 
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memory difficulties may be associated in part to executive deficits suggesting an 
interplay between memory and executive functions. Process score impairments 
were observed earlier than clinical decline on neuropsychological scores in this at-
risk cohort and might be useful cognitive markers of preclinical LOAD.
Keywords: Preclinical late-onset Alzheimer’s disease, RAVLT, executive 




The term “executive functions” (EF) is not a unitary concept, but rather is an 
umbrella term used for various complex cognitive processes that are critical for 
engagement in complex thought and behavior (Hazlett et al., 2015).  EF include 
numerous cognitive processes (i.e. planning, goal selection, set-shifting, working 
memory, self-monitoring, inhibition of inappropriate behavioral responses) 
associated with different regions within the frontal lobes – particularly the prefrontal 
cortex and the anterior cingulate – and are distributed throughout a wide network 
that includes parietal regions, subcortical structures and thalamic pathways 
(Jurado and Rosselli, 2007).
EF have been recently receiving growing attention in the Alzheimer’s disease (AD) 
literature. Specifically, deficits within this cognitive domain are associated with 
decreased functioning in activities of daily living, which represent an essential 
diagnostic criterion for a clinical diagnosis of AD (Hazlett et al., 2015). The 
presence of executive impairment is well established in mild and moderate AD 
(Albert, 1996; Binetti et al., 1996; Swanberg et al., 2004; Kirova et al., 2015; Blanco 
Martín et al., 2016) and, progressively, more authors are suggesting an early 
impairment in this cognitive domain which is usually present in prodromal AD and 
even in preclinical stages (Rapp and Reischies, 2005; Blacker et al., 2007; Johns 
et al., 2012; Reinvang et al., 2012; Ballard and O’Sullivan, 2013). Some 
investigators have even postulated that attention/executive mild cognitive 
impairment (MCI) is not a separate subtype of MCI but may be a precursor to 
amnestic MCI in those at risk for AD and thus, patients with nonamnestic 
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attention/executive impairment may develop memory problems later on (Reinvang 
et al., 2012).
Another reason for increasing interest in EF is that many of the cognitive tests that 
are most helpful in predicting which nondemented elderly will subsequently 
develop dementia include substantial executive control requirements (Brandt et al., 
2009), specifically, tests assessing episodic memory which is the most common 
and salient cognitive domain affected in AD (Baudic et al., 2006). A connection 
between memory and executive impairment in prodromal AD has been recently 
suggested (Hazlett et al., 2015) and some authors even propose that the early 
executive dysfunction may contribute to the upcoming memory deficit (Reinvang et 
al., 2012). There is evidence for statistically significant poorer performance of 
amnestic MCI patients on several tests of executive function (Johns et al., 2012; 
Zheng et al., 2012) and executive improvement derived from cognitive stimulation 
focused on EF on MCI patients generalized to memory performance (Moro et al., 
2015). The relationship between EF and memory impairment has not been 
thoroughly studied and may yield new insights regarding the neurobiology of MCI 
and preclinical AD (Libon et al., 2011). In fact, in the absence of hippocampal 
atrophy in healthy asymptomatic middle-aged offspring of late-onset AD (O-LOAD), 
our team observed decreased cortical thickness, abnormal cerebral metabolism, 
and incipient differences in amyloid deposition in precuneus, posterior cingulate, 
and prefrontal and temporal areas potentially associated with executive functioning 
rather than with episodic memory (Duarte-Abritta et al., 2018).
Most available studies address EF in either MCI or elderly populations while there 
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is a paucity of data on middle-aged samples with increased genetic risk of 
developing AD. In this context, Reinvang and his team (2012) propose that the 
search for cognitive markers in very early AD, that is, even prior to MCI should 
focus on subtle cognitive changes. Such changes may be as relevant as other 
preclinical AD markers (Thomas et al., 2018) and some researchers suggest that 
these subtle changes are as sensitive as, and sometimes superior to, 
neurobiological biomarkers at predicting progression to MCI and subsequently to 
AD-type dementia (Salmon and Bondi, 2009; Edmonds et al., 2015; Thomas et al., 
2018). Given that traditional global neuropsychological scores may be insensitive 
to the aforementioned subtle changes (Loewenstein et al., 2018b), a 
recommended approach to detect subtle cognitive decline is the implementation of 
a process scoring system, that is, the quantification of errors and strategies of an 
individual that could either hinder or aid performance as a means to determining 
how and why a final outcome (traditional score) was achieved and allows for a 
deeper understanding of the brain-behavior relationships underlying all cognitive 
functioning (Kaplan, 1988). Additionally, process scores are indicative of executive 
processing involved in other cognitive functions (Lezak et al., 2004). Along these 
lines, progressively more researchers have been implementing process-approach 
analysis to assess populations with increased risk of developing AD. Studies on 
memory tasks found reduced learning slope, increased intrusion errors and 
increased susceptibility to interference (Libon et al., 2011; Curiel et al., 2013; 
Sánchez et al., 2017; Abulafia et al., 2018; Thomas et al., 2018). Similar analyses 
have been also applied to EF tasks evidencing increased commission errors on 
tests of inhibition and cognitive flexibility (Wetter et al., 2005) as well as 
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asymmetric performance on fluency tasks (Houston et al., 2005). Very limited work 
has been conducted to assess EF abilities in healthy, young at-risk individuals. 
Recent findings suggested that EF were sensitive to subtle differences between 
cognitively intact elders with and without family history of AD (Donix et al., 2012) 
and between APOE4-carrying elders and non-carriers (Reinvang et al., 2010).
In the present study, asymptomatic and cognitively normal middle-aged O-LOAD 
participants were assessed with widely-used traditional tests of EF and then 
performed a process scoring system. The same analysis was applied to an 
episodic memory task extensively used to assess memory complaints, the Rey 
Auditory Verbal Learning Test (RAVLT), as a way to detect executive processes 
involved in eventual memory deficits. We hypothesized that O-LOAD would exhibit 
a reduced performance on EF tests together with increased errors and lower use of 
strategies. Further, we hypothesized that at this early stage of putative disease, 
any episodic memory deficits would be related to executive function abnormalities 
possibly related to encoding, retrieval, self-monitoring and/or inhibitory processes. 
Regarding memory performance, we predicted increased intrusion and interference 
errors on instances measuring both proactive and retroactive interference, and on 





An exploratory cross-sectional study was performed to compare cognitive 
measures between a sample of 32 offspring of late onset Alzheimer’s disease 
patients (O-LOAD) and 28 control subjects with no family history of AD (CS). Both 
groups were comparable in age, gender, education level, and depressive 
symptoms. All participants provided their written informed consent for the study as 
approved by the local bioethics committee and in accordance with the Declaration 
of Helsinki.
The inclusion criteria for O-LOAD were as follows: (1) having at least one parent 
diagnosed with probable LOAD according to the DSM-5 criteria, (2) to be 40–65 
years old at the time of recruitment, (3) having seven or more years of formal 
education, (4) Mini Mental State Examination (MMSE) score >26 (Folstein et al., 
1975), (5) no evidence of current progressive neurologic disease or medical 
conditions likely to impair cognitive function, (6) no history of substance abuse 
(alcohol, marijuana, stimulants, benzodiazepines, cocaine, or other illicit drugs), 
and (7) Hachinski score <4 to screen out subjects with potential vascular disease 
(Rosen et al., 1980).
All participants were asked to fill in names, dates of birth, age of AD onset, and 
clinical information of all affected family members. The information was confirmed 
with other family members and by interview with the examining physician, 
discussing the parents’ symptomatology and progression of disease. For 
individuals who had received no treatment at FLENI Foundation the parents’ 
diagnosis of LOAD was certified by a trained clinician from the institution. Only 
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individuals whose parents met DSM-5 criteria for probable AD and had lived to age 
≥65 were included.
The volunteers on the CS group had the same inclusion and exclusion criteria 
described above but were required to have no family history of neurodegenerative 
disease.
Cognitive Assessment
The neuropsychological tests included in this study have been widely validated and 
are frequently used in clinical practice and thus require no detailed explanation. For 
a thorough study of executive functions the following tests were selected: 
Backwards Digits subtest from WAIS III (working memory) (Weschler, 1997); the 
Trail Making Test (TMT) (Part B for cognitive flexibility and set-shifting) (Reitan and 
Wolfson, 1985); Design Fluency (DF) from the D-KEFS (nonverbal productivity, 
inhibition and set-shifting) (36); Phonetic Fluency (letter P) (verbal productivity) 
(Spreen and Benton, 1977); Similarities subtest from WAIS III (abstract thinking) 
(Weschler, 1997); Tower of London DX  (TOL) (planning and problem-solving) 
(Culbertson and Zillmer, 2001); and Stroop Test (inhibition on the Word-Color trial) 
(Golden, 1978). Finally, the Rey Auditory Verbal Learning Test (RAVLT) (Rey, 
1964; Schmidt, 1996) - which assesses verbal episodic memory - was incorporated 
to study the test’s inherent executive processes in detail as described below.
To ensure all participants were cognitively asymptomatic, a complete 
neuropsychological battery was implemented to assess all cognitive domains. The 
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individuals’ neuropsychological performance was within normal limits on all 
administered tests according to local norms, and thus none of the individuals met 
clinical criteria for mild cognitive impairment or dementia, nor did they exhibit 
subjective cognitive complaints.
The BDI-II questionnaire (Beck et al., 1996) was administered to screen for 
presence and severity of reported depressive symptoms which could impact 
cognitive performance. In our sample three CS and seven O-LOAD scored for mild 
depressive symptoms, but did not fulfill criteria for major depression. No impact on 
cognitive function was observed in these subjects. To estimate premorbid 
intelligence the WAT-BA test was administered and an estimated IQ was derived 
(Sierra Sanjurjo et al., 2015). All tests were administered and scored by a trained 
neuropsychologist blind to the participant´s group (CA).
Process approach scoring analysis
Additionally to standardized objective scoring, a process scoring analysis was 
performed on the RAVLT and EF tasks to measure both the amount and type of 
errors as well as use of strategies that could either hinder or aid performance 
respectively. 
Trail Making Test. The TMT B-A variable is a very common derived score of the 
TMT which calculates the difference between Part B and Part A. This derived score 
removes the speed component and reduces the visuoperceptual, motor and 
attentional demands of the TMT task which gives way to a purer indicator of 
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cognitive flexibility and executive control processes (Christidi et al., 2015). 
Additionally, errors on the TMT B were quantified and classified as Sequence 
Errors when subjects broke either the number sequence (e.g., 8 – H – 10) or the 
letter sequence (e.g., F – 7 – I) with preserved number-letter switching. Instances 
where subjects failed to alternate between numbers and letters were classified as 
Switching Errors.
Design Fluency. For each of the three conditions (1: Basic, 2: Filter, and 3: Switch) 
of the task, perseverative errors (Perseverations) were quantified whenever a 
design was repeated. Switching Errors were reported whenever subjects failed to 
alternate between empty and filled dots on the Switch condition. Moreover, use of 
a strategy for a more efficient performance was quantified. To our best knowledge, 
no strategies were delimited for the D-KEFS Design Fluency; therefore, we opted 
to implement the strategy criteria developed by Vik and Ruff (1988). The authors 
recognize the use of a strategy whenever three or more consecutive designs 
(strategic cluster) reflect a systematic rotation of either the whole design (including 
mirrored designs) or just a portion of it while the rest of the drawing remains fixed, 
Perseverative designs are not included as part of a strategic cluster if the original 
design has already appeared in that same cluster. However, the perseverative 
design can be included in a subsequent cluster. Given that most subjects 
generated no more than one cluster per condition (if any) this variable was 
dichotomized as presence/absence of at least one strategic cluster.
Verbal Fluency. Qualitative analysis of phonemic fluency (PF) was carried out 
following the guidelines developed by Troyer, Moscovitch and Winocur (1997). 
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Based on the concept of clusters, which are defined as groups of consecutive 
words that belong to a common semantic or phonemic subcategory, they propose 
two indicators of strategy use. Clustering (mean cluster size) involves effective 
word retrieval mechanisms from an internal word store. Switching (the number of 
transitions between clusters) reflects executive processes such as strategic search 
processes, cognitive flexibility and set-shifting. Besides strategies, perseverative 
responses were reported.
Stroop. We have quantified the incorrect responses as an additional measure of 
inhibitory control and self-monitoring. Spontaneous self-corrections were not 
recorded for this variable.
RAVLT. Besides traditionally reported variables of acquisition and recall, we 
measured performance errors throughout the task to assess self-monitoring: 
intrusions and repetitions throughout the learning slope (trials 1-5), List B, Trial 6 
and Delayed Recall, and only intrusions (not belonging to List B) on Recognition. 
To measure susceptibility to proactive interference List B interference errors (words 
belonging to List A) were recorded and List B performance was compared to Trial 
A1. For susceptibility to retroactive interference, interference errors (words 
belonging to List B) were quantified on Trial A6 and on Delayed Recall; and 
performance on A6 was compared to A5. Additionally, false positive responses 
belonging to List B on the Recognition trial (Recognition List B E) were recorded as 




Differences between groups were calculated using a t-test for independent 
samples for continuous variables. Chi-square tests were used for categorical 
variables. Correlations were evaluated using Spearman correlation coefficients. 
Exploratory studies in early stages such as the present project, aim at searching 
new hypothesis (Jaeger and Halliday, 1998) and thus minimizing Type II errors is 
strongly recommended (Reiner et al, 2003; McDondald, 2014). Therefore, an FDR 
correction at q = 0.2 was applied to multiple intergroup comparisons and the 
significance level of two-tailed tests was set at α = 0.05. All statistical analyses 
were performed using the SPSS version 22.0 software (SPSS Inc.).
Results
Table 1 depicts demographic and clinical characteristics of the current sample as 
well as standardized EF scores. Both groups were comparable in age, sex, years 
of education and premorbid intelligence. O-LOAD exhibited higher initiation time on 
the TOL than CS (p=.044) but the other TOL measures showed no difference of 
statistical relevance. Performance on the Stroop task was lower for O-LOAD 
compared to CS (p=.040). No additional differences were found for the rest of the 
EF tasks. Regarding the process-approach analysis of the EF tasks (Table 2), O-
LOAD showed increased switching errors on the TMT B when compared to CS 
(p=.029) as well as a greater number of errors on the Stroop task (p=.050). 
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Table 3 exhibits both traditional and process scores for the RAVLT. Maximum 
encoding (Trial A5) and the total learning slope showed better performance in CS 
(p=.030, p=.045, respectively). O-LOAD also exhibited decreased scores on 
delayed recall (p=.003) and recognition (p=.009) compared to CS. Regarding the 
process analysis, O-LOAD showed heightened susceptibility to proactive 
interference (List B (p=.006), B Interference E (p=.014), Trial B – A1 (p=.003)) as 
well as retroactive interference (Trial A6 Intrusion E, p=.024).
No significant correlations between Stroop and RAVLT measures were found for 
CS. However, O-LOAD exhibited positive correlations between de Stroop Word-
Color trial and the RAVLT’s Learning Curve (r=.437, p=.023), List B (r=.482, 
p=.009), and Delayed Recall (r=.506, p=.007). 
Discussion
This investigation represents an attempt to examine subtle deficits in executive 
function among middle-age O-LOAD individuals with no cognitive complaints and 
who were clinically asymptomatic. The main findings of the present study are that 
1) O-LOAD subjects exhibited a decreased executive performance compared to 
CS on the Tower of London (TOL)  initiation time and the Stroop Word-Color 
condition 2)  process approach scores of TMT B switching errors and Stroop errors 
were also greater in O-LOAD than CS; 3) RAVLT learning (Trial A5, Learning 
Slope), delayed recall and recognition showed a poorer performance on O-LOAD 
when compared to CS; 4) O-LOAD displayed increased proactive (List B, B 
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Interference E, Trial B – A1) and retroactive interference (Trial A6 Intrusion E) 
effects on the RAVLT compared to CS; and 5) positive correlations were found 
between the Stroop Word-Color trial and the learning curve, List  B, and delayed 
recall trials on the RAVLT only on O-LOAD.
Even though traditionally, a longer initiation time on the TOL reflects planning 
abilities, the fact that execution and total time showed no significant differences 
between groups suggests that O-LOAD did not benefit from longer planning time, 
therefore possibly indicating either an inefficient planning strategy or greater 
problem-solving difficulties to approach the task at hand. Differences on Stroop 
performance are more straightforward, evidencing greater susceptibility to 
interference effects in O-LOAD. This is further supported by the increased number 
of errors committed on the Stroop test, which are instances where subjects failed 
to inhibit interfering information. 
Another interesting finding when employing the process approach is the fact that 
even though both groups had a similar performance on the TMT B, O-LOAD 
participants exhibited more switching errors than CS, likely reflecting early, 
subclinical difficulties associated to cognitive flexibility processes.
We have already reported O-LOAD’s decreased anterograde memory performance 
(Abulafia et al., 2017), which reflects early subtle cognitive decline in subjects with 
increased risk of developing AD. The additional findings in this study support our 
hypothesis that such difficulties may be in part, associated with executive deficits 
rather than purely mnestic processes as described by the literature which states 
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that while the medial temporal lobes mediate memory storage, the frontal lobes are 
important for the acquisition and encoding of new information, and for the retrieval 
of the stored data as well as the recollection of source information (Dickerson and 
Atri, 2014). Our findings of reduced encoding and retrieval scores support this 
hypothesis. Additionally, proactive and retroactive interference effects during the 
process of encoding and recalling newly acquired information were observed in O-
LOAD subjects. These results are in line with previous findings of interference 
effects on memory tests (Libon et al., 2011; Loewenstein et al., 2017; Curiel et al., 
2018; Loewenstein et al., 2018a) which aim at the existence of an interplay 
between memory and executive processes. In a previous study, our team has 
reported such effects are already present in asymptomatic middle-aged individuals 
with family history of AD (Abulafia et al., 2018) providing further support that EF 
processes such as inhibition of irrelevant information play a key role in memory 
performance even in the absence of hippocampal atrophy (Duarte-Abritta et al., 
2018) and that executive impairment is not only present in all MCIs – including the 
so called “pure” amnestic groups – but also it may also act as a discriminating 
factor between prodromal AD and MCI (Brandt et al., 2009).
The present study has some limitations. Due to the cross-sectional nature of the 
study we cannot know if our participants will progress to aMCI and subsequently 
be diagnosed with LOAD. Thus, we cannot verify if the subtle changes reported 
herein will be predictive of the eventual development of the disease. Although our 
focus was on middle-age O-LOAD participants on executive measures that reflect 
process features, our sample was homogeneous in regards to ethnicity, 
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geographical area, culture, and years of education, thus probably limiting 
generalizability of the results. Additionally, all subjects completed at least 12 years 
of education - most even have university studies - therefore presenting high 
cognitive reserve levels which could be preventing the manifestation of greater 
subtle preclinical changes that would be otherwise present in individuals with lower 
cognitive reserve. The relatively modest number of participants would require that 
the present findings be confirmed in larger samples. Nonetheless, the current 
results have significant implications for understanding the earliest subtle executive 
changes in LOAD and is worthy of further research.
In sum, process scores such as intrusion errors or interference measures as the 
ones assessed in the present study are indicative of executive processes 
underlying other cognitive functions (Lezak et al., 2004). Recently, Curiel and 
associates (2018) showed that amyloid deposition was associated with semantic 
intrusion errors on tests of proactive semantic interference among individuals with 
aMCI on a cognitive stress test. This further bolsters the argument of the important 
function of inhibitory processes associated with AD. Process score impairments 
have been observed earlier than decline in neuropsychological test total scores in 
preclinical AD and might be useful cognitive markers of preclinical AD (Edmonds et 
al., 2015). This type of analysis is non-invasive and cost-effective and could help 
detect individuals at risk for cognitive decline before onset of overt cognitive 
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 Decreased executive performance was observed in offspring of patients with late-onset AD (O-
LOAD)
 O-LOAD exhibited increased Stroop and TMT B switching errors
 O-LOAD showed increased proactive and retroactive interference effects on the RAVLT
 In O-LOAD, response inhibition deficits explained in part poor episodic memory performance
 Disexecutive performance might appear earlier than memory deficits in preclinical LOAD
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Table 1. Demographic and clinical data
Group







Female 23 82.1% 22 68.8% X2= 1.429 .232
Age 52.21 7.59 54.59 6.81 T= -1.270 .209
Education 17.64 2.82 17.16 3.12 T= .623 .536
BDI II 8.04 7.37 8.40 6.64 T= -.189 .851
Estimated IQ 107.79 6.32 105.09 6.18 T= 1.672 .100
Backwards Digits 6.89 2.41 6.68 1.74 T= .390 .698
TMT B 63.61 17.54 70.53 19.07 T= -1.441 .155
DF 1 11.44 3.19 11.42 3.56 T= .028 .978
DF 2 12.37 3.71 12.03 3.30 T= .364 .717
DF 3 8 2.20 7.58 2.14 T= .733 .467
Phonetic Fluency 18.43 3.68 18.22 3.93 T= .213 .832
Similarities 26.04 4.09 25.55 4.54 T= .431 .668
TOL Number Correct 3.86 1.73 4.11 2.15 T= -.480 .633
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TOL Move Score 33.21 13.96 34.00 16.68 T= -.189 .851
TOL Initiation Time (s) 57.25 31.56 78.07 42.11 T= -2.069 .044
TOL Execution Time (s) 221.25 83.06 245.44 107.29 T= -.933 .355
TOL Total Time (s) 278.46 97.21 318.70 126.39 T= -1.320 .193
Stroop Word-Color 44.33 14.25 38.11 5.06 T= 2.144 .040
BDI II: Beck’s Depression Inventory, second edition; TMT B: Trail Making Test, part B; DF: Design 
Fluency; TOL: Tower of London. Comparisons surviving FDR correction are marked in bold.
Table 2. Executive Functions Process Scores
Group







TMT B-A 32.39 13.96 39.30 15.90 T= -1.761 .084
TMT B Sequencing. Errors .00 .00 .16 .45 T= -1.973 .057
TMT B Switching Errors .07 .26 .38 .71 T= -2.258 .029
DF 1 Clusters 8 28.6% 8 25% X2= .097 .755
DF 1 Perseverations 1.30 1.68 2.13 2.79 T= -1.396 .169
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DF 2 Clusters 5 17.9% 7 21.9% X2= .151 .698
DF 2 Perseverations 1.59 1.97 2.61 3.14 T= -1.503 .139
DF 3 Clusters 3 11.1% 4 12.9% X2= .044 .834
DF 3 Perseverations .63 .79 .71 1.44 T= -.266 .791
DF 3 Switching Errors .70 1.17 .58 .81 T= .459 .648
PF Switching 3.07 1.65 3.38 1.84 T= -.672 .504
PF Clustering 1.22 .39 1.50 .66 T= -2.001 .051
PF Perseverations .41 .69 .41 .76 T= .006 .995
Stroop Errors .36 .68 1.00 1.65 T= -2.022 .050
TMT: Trail Making Test; DF: Design Fluency; PF: Phonetic Fluency. Comparisons surviving FDR 
correction are marked in bold.
Table 3. Episodic memory data
Group







Trial A1 5.75 2.10 5.74 1.34 T= .017 .986
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Trial A5 11.86 1.45 10.84 2.03 T= 2.225 .030
Learning Slope 47.71 8.32 43.58 6.98 T= 2.055 .045
Learning Slope Intrusion E .86 1.64 1.66 2.18 T= -1.613 .112
Learning Slope Repetition E 3.43 3.16 3.77 3.06 T= -.426 .672
List B 6.11 1.97 4.72 1.75 T= 2.872 .006
B Intrusion E .11 .32 .25 .51 T= -1.326 .191
B Repetition E .32 .72 .16 .37 T= 1.052 .299
B Interference E .11 .42 .47 .67 T= -2.540 .014
Trial B - A1 .36 2.04 -1.13 1.48 T= 3.175 .003
Trial A6 9.71 2.02 8.50 2.89 T= 1.868 .067
Trial A6 Intrusion E .04 .19 .33 .66 T= -2.365 .024
Trial A6 Repetition E .54 .69 .73 1.11 T= -.818 .417
Trial A6 Interference E .07 .26 .26 .73 T= -1.333 .190
Trial A6 – A5 -2.14 1.53 -2.35 1.76 T= .494 .623
Delayed Recall 10.50 2.05 8.48 2.97 T= 3.064 .003
Delayed Recall Intrusion E .21 .50 .48 .77 T= -1.612 .113
Delayed Recall Repetition E .37 .63 .65 .98 T= -1.282 .206
Delayed Recall Interference E .04 .19 .10 .40 T= -.767 .447
Recognition 14.07 1.16 12.97 1.89 T= 2.738 .009
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Recognition - List B E .75 1.11 .65 1.08 T= .367 .715
Recognition - Intrusion E .57 1.26 .94 1.59 T= -.979 .332
E: Errors. Comparisons surviving FDR correction are marked in bold.
